Latest Articles

All Latest Articles

150411 Articles

Paul Ausick | Mar 15, 2016 at 4:01 PM EDT

The 4 Stocks That Held the Dow Up Slightly Monday

March 15, 2016: Markets opened lower again on Tuesday as crude oil prices continued a slide begun on Monday and…

Paul Ausick | Mar 15, 2016 at 2:24 PM EDT

TerraForm Power Filing Expected After Markets Close Tuesday

TerraForm Power filed a notice with the U.S. Securities and Exchange Commission on February 29 delaying the filing of its…

Paul Ausick | Mar 15, 2016 at 2:01 PM EDT

CEO Economic Forecast Remains Near 3-Year Low

Chief executive officers of large American companies are not becoming more upbeat on the U.S. economy in 2016 than they…

Chris Lange | Mar 15, 2016 at 1:15 PM EDT

SEC Charges Municipal Advisor for Failing to Disclose Conflict of Interest

The SEC has charged Kansas-based Central States Capital Markets, its chief executive officer and two employees for breaching their fiduciary…

Chris Lange | Mar 15, 2016 at 12:35 PM EDT

Celator Pharma Skyrockets on Breakthrough Trial Results

Celator Pharmaceuticals has announced positive results from its Phase 3 trial of Vyxeos Liposome for Injection in patients with high-risk…

Chris Lange | Mar 15, 2016 at 12:10 PM EDT

What to Look for in FedEx Earnings

FedEx is scheduled to report its fiscal third-quarter financial results Wednesday after the markets close.

Paul Ausick | Mar 15, 2016 at 11:50 AM EDT

Oil Companies Capex Down More Than 50% for 2016

The announced cuts to capital spending in the oil and gas exploration and production business average over 50%, with cuts…

Chris Lange | Mar 15, 2016 at 11:25 AM EDT

SEC Charges Microcap With Misleading Investors

The SEC has charged a microcap company's CEO for falsely claiming to have a lucrative relationship with the United Nations…

Chris Lange | Mar 15, 2016 at 11:20 AM EDT

SEC Settles With AIG Affiliates

The SEC has announced charges against three AIG affiliates for steering mutual fund clients toward more expensive share classes so…

Paul Ausick | Mar 15, 2016 at 11:15 AM EDT

Homebuilder Confidence Steady in March

In October 2015, the NAHB index reached 64, its highest level since the end of the housing boom in late…

Chris Lange | Mar 15, 2016 at 11:05 AM EDT

Aeglea BioTherapeutics Prepares for IPO

Aeglea BioTherapeutics has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Paul Ausick | Mar 15, 2016 at 10:55 AM EDT

February Retail Sales Slip 0.1%

The U.S. Census Bureau released advance estimates of retail and food services sales for February on Tuesday morning.

Lee Jackson | Mar 15, 2016 at 10:45 AM EDT

RBC Sees 4 Technology Buyout Candidates

In what is a yearly and very all-encompassing report, the analysts at RBC again go through every sector looking for…

Chris Lange | Mar 15, 2016 at 10:20 AM EDT

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be…

Chris Lange | Mar 15, 2016 at 10:05 AM EDT

Valeant Pharma Trips Over Preliminary Earnings and Guidance

Valeant Pharmaceuticals International reported mixed preliminary fourth-quarter financial results before the markets opened on Tuesday.

1 … 5,565 5,566 5,567 5,568 5,569 … 10,028

Latest Articles

All Latest Articles

The 4 Stocks That Held the Dow Up Slightly Monday

TerraForm Power Filing Expected After Markets Close Tuesday

CEO Economic Forecast Remains Near 3-Year Low

SEC Charges Municipal Advisor for Failing to Disclose Conflict of Interest

Celator Pharma Skyrockets on Breakthrough Trial Results

What to Look for in FedEx Earnings

Oil Companies Capex Down More Than 50% for 2016

SEC Charges Microcap With Misleading Investors

SEC Settles With AIG Affiliates

Homebuilder Confidence Steady in March

Aeglea BioTherapeutics Prepares for IPO

February Retail Sales Slip 0.1%

RBC Sees 4 Technology Buyout Candidates

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Valeant Pharma Trips Over Preliminary Earnings and Guidance

Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

The 1 Number That Might Make You Change Your Mind About When to Claim Social Security

How to Build $3,000 a Month in Dividend Income to Cover the Average Social Security Check

Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

Latest Articles

All Latest Articles

The 4 Stocks That Held the Dow Up Slightly Monday

TerraForm Power Filing Expected After Markets Close Tuesday

CEO Economic Forecast Remains Near 3-Year Low

SEC Charges Municipal Advisor for Failing to Disclose Conflict of Interest

Celator Pharma Skyrockets on Breakthrough Trial Results

What to Look for in FedEx Earnings

Oil Companies Capex Down More Than 50% for 2016

SEC Charges Microcap With Misleading Investors

SEC Settles With AIG Affiliates

﻿﻿Homebuilder Confidence Steady in March

Aeglea BioTherapeutics Prepares for IPO

February Retail Sales Slip 0.1%

RBC Sees 4 Technology Buyout Candidates

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Valeant Pharma Trips Over Preliminary Earnings and Guidance

Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

Featured Reads

The 1 Number That Might Make You Change Your Mind About When to Claim Social Security

How to Build $3,000 a Month in Dividend Income to Cover the Average Social Security Check

Homebuilder Confidence Steady in March